Millions of diabetics inject insulin daily, and millions more are on the path to injections. But Oramed Pharmaceuticals aims to change that reality, with an insulin pill. Currently in clinical trials, the oral insulin capsule will could radically change how we treat diabetes, and dramatically change the lives of diabetic patients. Oramed Pharmaceuticals CEO Nadav Kidron explains the technology behind their oral insulin development.
Millions of diabetics inject insulin daily, and millions more are on the path to injections. But Oramed Pharmaceuticals aims to change that reality, with an insulin pill. Currently in clinical trials, the oral insulin capsule will could radically change how we treat diabetes, and dramatically change the lives of diabetic patients. Oramed Pharmaceuticals CEO Nadav Kidron explains the technology behind their oral insulin development.
Posted
and last updated
Copyright 2018 Scripps Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.